BiomX to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022

Rhea-AI Summary

BiomX Inc. (PHGE), a clinical-stage microbiome company, announced a conference call on November 9, 2022, at 8:00 a.m. ET to discuss its third quarter 2022 financial results and provide business updates. The conference will be accessible via phone or through a live audio webcast on the company's website. BiomX focuses on developing natural and engineered phage therapies aimed at treating chronic diseases by targeting specific pathogenic bacteria. More details can be found on their website.

Positive

• Upcoming conference call to discuss Q3 2022 financial results
• Focus on innovative phage therapies targeting chronic diseases

Negative

• None.

NESS ZIONA, Israel, Nov. 02, 2022 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, November 9, 2022, at 8:00 a.m. ET, to report third quarter 2022 financial results and provide business updates.

To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.

About BiomX

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available at www.biomx.com, the content of which does not form a part of this press release.

BiomX, Inc.
Anat Primovich
Corporate Project Manager
+97250-6977228
anatp@biomx.com 

Investor Relations:
LifeSci Advisors, LLC
John Mullaly
jmullaly@lifesciadvisors.com 

Source: BiomX Inc

FAQ

What are BiomX's plans for November 9, 2022?

BiomX will host a conference call to report its third quarter 2022 financial results and provide business updates.

How can I participate in BiomX's conference call?

You can participate by dialing 1-877-407-0724 for the U.S. or 1-201-389-0898 for international calls.

What is BiomX's focus in their research?

BiomX focuses on developing novel natural and engineered phage therapies to target specific pathogenic bacteria.